Haemonetics HAE
NYSE HAE
$108.58 +0.17 (+0.16%)
At close: Aug 20, 2026 · 10:17 AM UTC

Haemonetics (HAE) Return on Capital Employed Growth (1y) (2011 - 2026)

Haemonetics (HAE) Return on Capital Employed Growth (1y) (2011 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE Growth (1y) (Qtr)
1 Abbott Laboratories 199.70 Bn 194.09 Bn 7.27 Bn -286.00
2 Stryker 129.93 Bn 126.46 Bn 4.50 Bn 6,388.00
3 Medtronic 120.49 Bn 111.27 Bn 6.41 Bn 39.00
4 Boston Scientific 74.60 Bn 74.06 Bn 3.85 Bn 200.00
5 Edwards Lifesciences 52.68 Bn 48.42 Bn 1.35 Bn -41.00
6 Dexcom 34.78 Bn 32.84 Bn 830.00 Mn 879.00
7 GE HealthCare Technologies 33.83 Bn 31.72 Bn 2.18 Bn -2,494.00
8 Koninklijke Philips 26.44 Bn 23.12 Bn 4.55 Bn 632.00
9 Steris 23.18 Bn 22.69 Bn 684.20 Mn 216.00
10 Haemonetics 4.93 Bn 4.70 Bn 202.80 Mn -468.00

Historic Data

Download Data
DateValue
Jun 27, 2026 -468.00
Mar 28, 2026 -434.00
Dec 27, 2025 510.00
Sep 27, 2025 534.00
Jun 28, 2025 509.00
Mar 29, 2025 291.00
Dec 28, 2024 -130.00
Sep 28, 2024 -232.00
Jun 29, 2024 -329.00
Mar 30, 2024 -74.00
Dec 30, 2023 72.00
Sep 30, 2023 135.00
Jul 1, 2023 382.00
Apr 1, 2023 368.00
Dec 31, 2022 575.00
Oct 1, 2022 538.00
Jul 2, 2022 160.00
Apr 2, 2022 -107.00
Jan 1, 2022 -890.00
Oct 2, 2021 -965.00